Showing 1,421 - 1,440 results of 1,863 for search '"Hangzhou"', query time: 0.04s Refine Results
  1. 1421
  2. 1422
  3. 1423
  4. 1424
  5. 1425
  6. 1426
  7. 1427

    A Rare Case Report: Primary Vulvar Adenocarcinoma of Mammary Gland Type by Dai X, Lei H, Jie R

    Published 2025-02-01
    “…Xiaomin Dai, Huan Lei, Ruixia Jie Department of Pathology, Zhejiang Hospital, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Ruixia Jie, Email 632331879@qq.comAbstract: Primary vulvar adenocarcinoma of mammary gland type (AMGT) is exceedingly rare and presents significant diagnostic challenges. …”
    Get full text
    Article
  8. 1428

    Multiple Disturbances of Existing Tunnels Caused by Deep Excavation and New Shield Tunnel by Haoran Li, Fei Ye, Enjie Su, Xingbo Han

    Published 2023-01-01
    “…Taking a section ranging from the Chengzhan Station to the Jiangcheng Road Station of Hangzhou Metro Line 7 as a case study, this study analyzes the automatic monitoring data of the existing tunnel within this section. …”
    Get full text
    Article
  9. 1429
  10. 1430
  11. 1431
  12. 1432
  13. 1433
  14. 1434
  15. 1435
  16. 1436
  17. 1437
  18. 1438
  19. 1439

    Co-Delivery of Dacarbazine and miRNA 34a Combinations to Synergistically Improve Malignant Melanoma Treatments by Ding B, Li M, Zhang J, Zhang X, Gao H, Gao J, Shen C, Zhou Y, Li F, Liu A

    Published 2025-01-01
    “…Baoyue Ding,1,2,* Mingjuan Li,2,* Jie Zhang,2,* Xiaojuan Zhang,2 Huan Gao,2 Jianqing Gao,3 Chunyan Shen,4 Yan Zhou,4 Fanzhu Li,5 Ailin Liu1 1Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou, 350122, People’s Republic of China; 2Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, Jiaxing University College of Medicine, Jiaxing, Zhejiang, People’s Republic of China; 3Institute of Pharmaceutics, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058 People’s Republic of China; 4Jiaxing Institute for Food, Drug and Product Quality Control, Jiaxing, Zhejiang, People’s Republic of China; 5Zhejiang Chinese Medical University, School of Pharmaceutical Science, Hangzhou, 310053, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fanzhu Li; Ailin Liu, Email lifanzhu@zcmu.edu.cn; ailinliu@mail.fjmu.edu.cnPurpose: The incidence of malignant melanoma (MM) has risen over the past three decades, and despite advancements in treatment, there is still a need to improve treatment modalities. …”
    Get full text
    Article
  20. 1440